6 found
Order:
  1.  25
    Do Physicians’ Own Preferences for Life-Sustaining Treatment Influence Their Perceptions of Patients’ Preferences?Lawrence J. Schneiderman, Robert M. Kaplan, Robert A. Pearlman & Holly Teetzel - 1993 - Journal of Clinical Ethics 4 (1):28-33.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   11 citations  
  2.  20
    Long-Term Physical Exercise and Mindfulness Practice in an Aging Population.Yi-Yuan Tang, Yaxin Fan, Qilin Lu, Li-Hai Tan, Rongxiang Tang, Robert M. Kaplan, Marco C. Pinho, Binu P. Thomas, Kewei Chen, Karl J. Friston & Eric M. Reiman - 2020 - Frontiers in Psychology 11.
  3.  64
    Do physicians' own preferences for life-sustaining treatment influence their perceptions of patients' preferences? A second look.Lawrence J. Schneiderman, Robert M. Kaplan, Esther Rosenberg & Holly Teetzel - 1997 - Cambridge Quarterly of Healthcare Ethics 6 (2):131-.
    Previous studies have documented the fallibility of attempts by surrogates and physicians to act in a substituted judgment capacity and predict end-of-life treatment decisions on behalf of patients. We previously reported that physicians misperceive their patients' preferences and substitute their own preferences for those of their patients with respect to four treatments: cardiopulmonary resuscitation in the event of cardiac arrest, ventilator for an indefinite period of time, medical nutrition and hydration for an indefinite period of time, and hospitalization in the (...)
    Direct download (6 more)  
     
    Export citation  
     
    Bookmark   3 citations  
  4.  5
    Sickening: who is protecting pharma consumers?Robert M. Kaplan - 2023 - Perspectives in Biology and Medicine 66 (2):327-343.
    ABSTRACT:In 2022, John Abramson published Sickening: How Big Pharma Broke American Healthcare and How We Can Repair It. The book illustrates how large pharmaceutical companies have become misinformation machines that have corrupted peer-reviewed journals, systematic review authors, and guideline committees. Industry influence includes selective reporting of clinical trial results and selection of control groups likely to enhance benefits and disguise side effects. Other documented forms of influence include clear conflicts of interest for members of guideline committees and even direct intimidation. (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  5.  8
    Attitudes of Seriously Ill Patients toward Treatment that Involves High Costs and Burdens on Others.Robert D. Langer, John P. Anderson, Robert M. Kaplan, Richard Kronick & Lawrence J. Schneiderman - 1994 - Journal of Clinical Ethics 5 (2):109-112.
    No categories
    Direct download  
     
    Export citation  
     
    Bookmark   1 citation  
  6.  34
    Do Physicians' Own Preferences for Life-Sustaining Treatment Influence Their Perceptions of Patients' Preferences? A Second Look.Lawrence J. Schneiderman, Robert M. Kaplan, Esther Rosenberg & Holly Teetzel - 1997 - Cambridge Quarterly of Healthcare Ethics 6 (2):131-137.
    Previous studies have documented the fallibility of attempts by surrogates and physicians to act in a substituted judgment capacity and predict end-of-life treatment decisions on behalf of patients. We previously reported that physicians misperceive their patients' preferences and substitute their own preferences for those of their patients with respect to four treatments: cardiopulmonary resuscitation (CPR) in the event of cardiac arrest, ventilator for an indefinite period of time, medical nutrition and hydration for an indefinite period of time, and hospitalization in (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   1 citation